Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease

Documenti analoghi

• CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline
  di: Jon Rodriguez‐Antiguedad, et al.
  Pubblicazione: (2025)
• Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers
  di: Arnau Puig‐Davi, et al.
  Pubblicazione: (2024)
• A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's
  di: Natalia E. Owen, et al.
  Pubblicazione: (2025)
• Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test
  di: Jessie Fanglu Fu, et al.
  Pubblicazione: (2025)
• Modifiable factors associated with Huntington's disease progression in presymptomatic participants
  di: Andres Gil‐Salcedo, et al.
  Pubblicazione: (2024)